Review – Valproic Acid and Autism

What We Have Learned about Autism Spectrum Disorder from Valproic Acid.

http://www.ncbi.nlm.nih.gov/pubmed/24381784

Full Paper at Link

Abstract

Two recent epidemiological investigations in children exposed to valproic acid (VPA) treatment in utero have reported a significant risk associated with neurodevelopmental disorders and autism spectrum disorder (ASD) in particular.

Parallel to this work, there is a growing body of animal research literature using VPA as an animal model of ASD.

In this focused review we first summarize the epidemiological evidence linking VPA to ASD and then comment on two important neurobiological findings linking VPA to ASD clinicopathology, namely, accelerated or early brain overgrowth and hyperexcitable networks.

Improving our understanding of how the drug VPA can alter early development of neurological systems will ultimately improve our understanding of ASD.

Advertisements
This entry was posted in Autism, co-morbid, Environment, Gut, Immune System, Inflammation, Mice, Neurology, Physiology, Treatment. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s